VAERS reports by lot

GSK DTaP/Tdap lot 9PD92: VAERS reports

21 VAERS reports list lot 9PD92 as a GSK DTaP/Tdap vaccine, received between 2018-03-21 and 2019-11-05. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
21
Reports
5%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3037%
General / Systemic (non-local)1215%
Neurological911%
Cardiac / Cardiovascular79%
Musculoskeletal79%
Dermatological (non-injection-site)79%
Gastrointestinal56%
Respiratory22%
Thrombotic / Hematological11%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 12).

North Carolina3
California3
Texas2
Kansas1
South Carolina1
Indiana1
Michigan1
Alaska1
Missouri1
Virginia1
Florida1
South Dakota1

Reports by month received

2018-031
2018-045
2018-053
2018-063
2018-074
2018-092
2018-101
2019-021
2019-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.